White matter diffusion alterations precede symptom onset in autosomal dominant Alzheimer’s disease
暂无分享,去创建一个
Martin Rossor | Michael Weiner | Clifford R Jack | Adrian Danek | Nick C Fox | Igor Yakushev | Martin Dichgans | Marco Duering | Peter R Schofield | Nicolai Franzmeier | Michael Ewers | Stephen Salloway | Colin L Masters | Randall J Bateman | Jason Hassenstab | Johannes Levin | Mathias Jucker | Christian Haass | Celeste Karch | Tammie Benzinger | A. Fagan | J. Morris | C. Jack | M. Rossor | S. Salloway | R. Bateman | C. Masters | P. Schofield | M. Weiner | M. Ewers | A. Danek | M. Dichgans | A. Goate | M. Jucker | J. Hassenstab | T. Benzinger | M. Duering | I. Yakushev | C. Haass | N. Franzmeier | M. Suárez-Calvet | Jae-Hong Lee | M. Á. Araque Caballero | J. Levin | Anne M Fagan | John C Morris | Jae-Hong Lee | Alison Goate | Marc Suárez-Calvet | Miguel Ángel Araque Caballero | C. Karch | J. Morris | J. Morris | J. Morris
[1] C. Jack,et al. Anterior temporal lobes and hippocampal formations: normative volumetric measurements from MR images in young adults. , 1989, Radiology.
[2] C. Jack,et al. Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers , 2013, The Lancet Neurology.
[3] Lin Zhuang,et al. Is Alzheimer's a disease of the white matter? , 2013, Current opinion in psychiatry.
[4] Daniel C Alexander,et al. Data-driven models of dominantly-inherited Alzheimer’s disease progression , 2018, bioRxiv.
[5] Stephen M. Smith,et al. Threshold-free cluster enhancement: Addressing problems of smoothing, threshold dependence and localisation in cluster inference , 2009, NeuroImage.
[6] R. Kalaria,et al. Taxifolin inhibits amyloid-β oligomer formation and fully restores vascular integrity and memory in cerebral amyloid angiopathy , 2017, Journal of the Neurological Sciences.
[7] Stephen M. Smith,et al. DTI measures in crossing-fibre areas: Increased diffusion anisotropy reveals early white matter alteration in MCI and mild Alzheimer's disease , 2011, NeuroImage.
[8] D. Selkoe. Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.
[9] William N. Venables,et al. Modern Applied Statistics with S , 2010 .
[10] David M Holtzman,et al. Cerebrovascular Dysfunction in Amyloid Precursor Protein Transgenic Mice: Contribution of Soluble and Insoluble Amyloid-β Peptide, Partial Restoration via γ-Secretase Inhibition , 2008, The Journal of Neuroscience.
[11] H. Feldman,et al. Periventricular hyperintensities are associated with elevated cerebral amyloid , 2016, Neurology.
[12] Maxim N. Artyomov,et al. TREM2 Maintains Microglial Metabolic Fitness in Alzheimer’s Disease , 2017, Cell.
[13] N. Schuff,et al. Multimodal imaging in Alzheimer's disease: validity and usefulness for early detection , 2015, The Lancet Neurology.
[14] A. Alexander,et al. Diffusion tensor imaging of the brain , 2007, Neurotherapeutics.
[15] Andrew Dumas,et al. Functional magnetic resonance imaging detection of vascular reactivity in cerebral amyloid angiopathy , 2012, Annals of neurology.
[16] Yi Su,et al. The relationship between cerebrospinal fluid markers of Alzheimer pathology and positron emission tomography tau imaging. , 2016, Brain : a journal of neurology.
[17] George Bartzokis,et al. Diffusion tensor imaging in preclinical and presymptomatic carriers of familial Alzheimer's disease mutations. , 2007, Brain : a journal of neurology.
[18] P. Visser,et al. New MRI markers for Alzheimer's disease: a meta-analysis of diffusion tensor imaging and a comparison with medial temporal lobe measurements. , 2012, Journal of Alzheimer's disease : JAD.
[19] L. Wahlund,et al. The association between biomarkers in cerebrospinal fluid and structural changes in the brain in patients with Alzheimer's disease , 2014, Journal of internal medicine.
[20] Yong-An Chung,et al. Hypoperfusion and Ischemia in Cerebral Amyloid Angiopathy Documented by 99mTc-ECD Brain Perfusion SPECT , 2009, Journal of Nuclear Medicine.
[21] Cindee M. Madison,et al. Cerebrovascular disease, beta-amyloid, and cognition in aging , 2012, Neurobiology of Aging.
[22] C. Jack,et al. Vascular and amyloid pathologies are independent predictors of cognitive decline in normal elderly , 2015, Brain : a journal of neurology.
[23] V. Calhoun,et al. Selective changes of resting-state networks in individuals at risk for Alzheimer's disease , 2007, Proceedings of the National Academy of Sciences.
[24] Vito Paolo Pastore,et al. Sphingomyelin as a myelin biomarker in CSF of acquired demyelinating neuropathies , 2017, Scientific Reports.
[25] S. M. de la Monte. Quantitation of cerebral atrophy in preclinical and end‐stage alzheimer's disease , 1989, Annals of neurology.
[26] Derek K. Jones,et al. Investigating the prevalence of complex fiber configurations in white matter tissue with diffusion magnetic resonance imaging , 2013, Human brain mapping.
[27] R. Weller,et al. Microvasculature changes and cerebral amyloid angiopathy in Alzheimer’s disease and their potential impact on therapy , 2009, Acta Neuropathologica.
[28] Sterling C. Johnson,et al. Association of longitudinal white matter degeneration and cerebrospinal fluid biomarkers of neurodegeneration, inflammation and Alzheimer’s disease in late-middle-aged adults , 2019, Brain Imaging and Behavior.
[29] Robert I. Reid,et al. White matter integrity determined with diffusion tensor imaging in older adults without dementia: influence of amyloid load and neurodegeneration. , 2014, JAMA neurology.
[30] Robert I. Reid,et al. White-matter integrity on DTI and the pathologic staging of Alzheimer's disease , 2017, Neurobiology of Aging.
[31] Nick C Fox,et al. A data-driven model of biomarker changes in sporadic Alzheimer's disease , 2014, Alzheimer's & Dementia.
[32] D. Bennett,et al. White matter changes in mild cognitive impairment and AD: A diffusion tensor imaging study , 2006, Neurobiology of Aging.
[33] Reisa A. Sperling,et al. Longitudinal Change in CSF Biomarkers in Autosomal-Dominant Alzheimer’s Disease , 2014, Science Translational Medicine.
[34] Anders H. Andersen,et al. Alterations in multiple measures of white matter integrity in normal women at high risk for Alzheimer's disease , 2010, NeuroImage.
[35] Dominic Holland,et al. Amyloid‐β associated volume loss occurs only in the presence of phospho‐tau , 2011, Annals of neurology.
[36] Jorge Sepulcre,et al. Structural tract alterations predict down-stream tau accumulation in amyloid positive older individuals , 2018, Nature Neuroscience.
[37] Nick C Fox,et al. Regional variability of imaging biomarkers in autosomal dominant Alzheimer’s disease , 2013, Proceedings of the National Academy of Sciences.
[38] Marc Modat,et al. The Importance of Group-Wise Registration in Tract Based Spatial Statistics Study of Neurodegeneration: A Simulation Study in Alzheimer's Disease , 2012, PloS one.
[39] Carlo Pierpaoli,et al. Effects of image distortions originating from susceptibility variations and concomitant fields on diffusion MRI tractography results , 2012, NeuroImage.
[40] Klaus P. Ebmeier,et al. A meta-analysis of diffusion tensor imaging in mild cognitive impairment and Alzheimer's disease , 2011, Neurobiology of Aging.
[41] Massimo Filippi,et al. White matter damage in Alzheimer disease and its relationship to gray matter atrophy. , 2011, Radiology.
[42] J. Molinuevo,et al. TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis , 2014, Science Translational Medicine.
[43] Harald Hampel,et al. Fiber connections between the cerebral cortex and the corpus callosum in Alzheimer's disease: a diffusion tensor imaging and voxel-based morphometry study. , 2007, Cerebral cortex.
[44] Thomas R. Knösche,et al. White matter integrity, fiber count, and other fallacies: The do's and don'ts of diffusion MRI , 2013, NeuroImage.
[45] Nick C Fox,et al. Magnetic resonance imaging evidence for presymptomatic change in thalamus and caudate in familial Alzheimer’s disease , 2013, Brain : a journal of neurology.
[46] Sterling C. Johnson,et al. CSF T-Tau/Aβ42 Predicts White Matter Microstructure in Healthy Adults at Risk for Alzheimer’s Disease , 2012, PloS one.
[47] M. Filippi,et al. White matter damage in Alzheimer's disease assessed in vivo using diffusion tensor magnetic resonance imaging , 2002, Journal of neurology, neurosurgery, and psychiatry.
[48] Stefan Klein,et al. Improving alignment in Tract-based spatial statistics: Evaluation and optimization of image registration , 2013, NeuroImage.
[49] B. Zlokovic. Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders , 2011, Nature Reviews Neuroscience.
[50] C. Haass,et al. An Alzheimer‐associated TREM2 variant occurs at the ADAM cleavage site and affects shedding and phagocytic function , 2017, EMBO molecular medicine.
[51] Bixente Dilharreguy,et al. Age-Related Modifications of Diffusion Tensor Imaging Parameters and White Matter Hyperintensities as Inter-Dependent Processes , 2016, Front. Aging Neurosci..
[52] P. Nestor,et al. Diffusion tensor imaging in Alzheimer's disease: insights into the limbic-diencephalic network and methodological considerations , 2014, Front. Aging Neurosci..
[53] W. M. van der Flier,et al. Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline , 2017, Alzheimer's Research & Therapy.
[54] D. Borchelt,et al. SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein , 1999, Nature Neuroscience.
[55] Nick C Fox,et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration , 2013, The Lancet Neurology.
[56] Alexander Leemans,et al. The B‐matrix must be rotated when correcting for subject motion in DTI data , 2009, Magnetic resonance in medicine.
[57] R. Righart,et al. Incident subcortical infarcts induce focal thinning in connected cortical regions , 2012, Neurology.
[58] Andrew J. Saykin,et al. Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer disease: a longitudinal study , 2018, The Lancet Neurology.
[59] Lino C. Gonzalez,et al. TREM2 Binds to Apolipoproteins, Including APOE and CLU/APOJ, and Thereby Facilitates Uptake of Amyloid-Beta by Microglia , 2016, Neuron.
[60] A. Brun,et al. A white matter disorder in dementia of the Alzheimer type: A pathoanatomical study , 1986, Annals of neurology.
[61] A. Evans,et al. Correction for partial volume effects in PET: principle and validation. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[62] K. Blennow,et al. sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early‐stage Alzheimer's disease and associate with neuronal injury markers , 2016, EMBO molecular medicine.
[63] S. Younkin,et al. Apolipoprotein E Is a Ligand for Triggering Receptor Expressed on Myeloid Cells 2 (TREM2)* , 2015, The Journal of Biological Chemistry.
[64] D. Holtzman,et al. TREM2 lipid sensing sustains microglia response in an Alzheimer’s disease model , 2015, Cell.
[65] D. Boas,et al. Pericyte degeneration leads to neurovascular uncoupling and limits oxygen supply to brain , 2017, Nature Neuroscience.
[66] M. Bastin,et al. Memory binding and white matter integrity in familial Alzheimer's disease. , 2015, Brain : a journal of neurology.
[67] S. Ropele,et al. Incident lacunes preferentially localize to the edge of white matter hyperintensities: insights into the pathophysiology of cerebral small vessel disease. , 2013, Brain : a journal of neurology.
[68] Guy B. Williams,et al. Diffusion Tensor Metrics as Biomarkers in Alzheimer's Disease , 2012, PloS one.
[69] Sterling C. Johnson,et al. White matter is altered with parental family history of Alzheimer's disease , 2010, Alzheimer's & Dementia.
[70] D. Nation,et al. Cerebrovascular resistance: effects on cognitive decline, cortical atrophy, and progression to dementia , 2017, Brain : a journal of neurology.
[71] G. Frisoni,et al. Fractional anisotropy changes in Alzheimer's disease depend on the underlying fiber tract architecture: a multiparametric DTI study using joint independent component analysis. , 2014, Journal of Alzheimer's disease : JAD.
[72] Andrew Zalesky,et al. Moderating registration misalignment in voxelwise comparisons of DTI data: a performance evaluation of skeleton projection. , 2011, Magnetic resonance imaging.
[73] Randy L. Gollub,et al. Reproducibility of quantitative tractography methods applied to cerebral white matter , 2007, NeuroImage.
[74] W. Wurst,et al. The FTD‐like syndrome causing TREM2 T66M mutation impairs microglia function, brain perfusion, and glucose metabolism , 2017, The EMBO journal.
[75] A. Singleton,et al. TREM2 variants in Alzheimer's disease. , 2013, The New England journal of medicine.
[76] K. Krishnan,et al. Evidence of white matter tract disruption in MRI hyperintensities , 2001, Biological Psychiatry.
[77] W. Jagust,et al. Vascular burden and Alzheimer disease pathologic progression , 2012, Neurology.
[78] J. Molinuevo,et al. White Matter Abnormalities Track Disease Progression in PSEN1 Autosomal Dominant Alzheimer's Disease. , 2016, Journal of Alzheimer's disease : JAD.
[79] M. Farzan,et al. The Triggering Receptor Expressed on Myeloid Cells 2 Binds Apolipoprotein E* , 2015, The Journal of Biological Chemistry.
[80] Klaus H. Maier-Hein,et al. Methodological considerations on tract-based spatial statistics (TBSS) , 2014, NeuroImage.
[81] Charles D. Smith,et al. White matter integrity and vulnerability to Alzheimer's disease: preliminary findings and future directions. , 2012, Biochimica et biophysica acta.
[82] R. Kahn,et al. Functionally linked resting‐state networks reflect the underlying structural connectivity architecture of the human brain , 2009, Human brain mapping.
[83] Lin Zhuang,et al. Microstructural white matter changes in cognitively normal individuals at risk of amnestic MCI , 2012, Neurology.
[84] F. Barkhof,et al. Disrupted white matter structural networks in healthy older adult APOE ε4 carriers – An international multicenter DTI study , 2017, Neuroscience.
[85] Nick C Fox,et al. White matter hyperintensities are a core feature of Alzheimer's disease: Evidence from the dominantly inherited Alzheimer network , 2016, Annals of neurology.
[86] Norbert Schuff,et al. Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis , 2016, Nature Communications.
[87] R. Kalaria. Neuropathological diagnosis of vascular cognitive impairment and vascular dementia with implications for Alzheimer’s disease , 2016, Acta Neuropathologica.
[88] Elisabet Englund,et al. Neuropathology of White Matter Changes in Alzheimer’s Disease and Vascular Dementia , 1998, Dementia and Geriatric Cognitive Disorders.
[89] Guy B. Williams,et al. Absolute diffusivities define the landscape of white matter degeneration in Alzheimer's disease. , 2010, Brain : a journal of neurology.
[90] Matthew L Senjem,et al. Shapes of the trajectories of 5 major biomarkers of Alzheimer disease. , 2012, Archives of neurology.
[91] Nick C Fox,et al. Clinical and biomarker changes in dominantly inherited Alzheimer's disease. , 2012, The New England journal of medicine.
[92] Alexander N. W. Taylor,et al. Tract-specific white matter hyperintensities disrupt neural network function in Alzheimer's disease , 2017, Alzheimer's & Dementia.
[93] Ping Zhou,et al. Nox2-derived radicals contribute to neurovascular and behavioral dysfunction in mice overexpressing the amyloid precursor protein , 2008, Proceedings of the National Academy of Sciences.
[94] Daniel Rueckert,et al. Tract-based spatial statistics: Voxelwise analysis of multi-subject diffusion data , 2006, NeuroImage.
[95] A. Hofman,et al. Variant of TREM2 associated with the risk of Alzheimer's disease. , 2013, The New England journal of medicine.
[96] Chengjie Xiong,et al. Impaired default network functional connectivity in autosomal dominant Alzheimer disease , 2013, Neurology.
[97] Peter A. Calabresi,et al. Tract probability maps in stereotaxic spaces: Analyses of white matter anatomy and tract-specific quantification , 2008, NeuroImage.
[98] W. Wurst,et al. TREM2 deficiency impairs chemotaxis and microglial responses to neuronal injury , 2017, EMBO reports.
[99] D. Prvulovic,et al. Using Support Vector Machines with Multiple Indices of Diffusion for Automated Classification of Mild Cognitive Impairment , 2012, PloS one.
[100] F. de Leeuw,et al. A Novel Imaging Marker for Small Vessel Disease Based on Skeletonization of White Matter Tracts and Diffusion Histograms , 2016, Annals of neurology.
[101] Henry Rusinek,et al. Reduced glucose uptake and Aβ in brain regions with hyperintensities in connected white matter , 2014, NeuroImage.
[102] Norbert Schuff,et al. White matter damage in frontotemporal dementia and Alzheimer's disease measured by diffusion MRI , 2009, Brain : a journal of neurology.
[103] Gina N. LaRossa,et al. [11C]PIB in a nondemented population , 2006, Neurology.
[104] M. Weiner,et al. Amyloid Associated Intermittent Network Disruptions in Cognitively Intact Older Subjects: Structural Connectivity Matters , 2017, Front. Aging Neurosci..
[105] Stephen M. Smith,et al. Permutation inference for the general linear model , 2014, NeuroImage.
[106] Harald Hampel,et al. Progression of corpus callosum atrophy in Alzheimer disease. , 2002, Archives of neurology.
[107] J. Molinuevo,et al. Multiple DTI index analysis in normal aging, amnestic MCI and AD. Relationship with neuropsychological performance , 2012, Neurobiology of Aging.
[108] David N. Vaughan,et al. Fibre-specific white matter reductions in Alzheimer’s disease and mild cognitive impairment , 2018, Brain : a journal of neurology.
[109] Adrian Danek,et al. Early changes in CSF sTREM2 in dominantly inherited Alzheimer’s disease occur after amyloid deposition and neuronal injury , 2016, Science Translational Medicine.
[110] Nick C Fox,et al. Symptom onset in autosomal dominant Alzheimer disease , 2014, Neurology.
[111] Jeannie-Marie S. Leoutsakos,et al. Longitudinal, region-specific course of diffusion tensor imaging measures in mild cognitive impairment and Alzheimer’s disease , 2013, Alzheimer's & Dementia.
[112] S. M. de la Monte,et al. Quantitation of cerebral atrophy in preclinical and end‐stage alzheimer's disease , 1989, Annals of neurology.
[113] Daniel C. Alexander,et al. NODDI: Practical in vivo neurite orientation dispersion and density imaging of the human brain , 2012, NeuroImage.